Treatment of Livedoid Vasculopathy With Rivaroxaban: A Potential Use of New Oral Anticoagulants for Dermatologists

Actas Dermosifiliogr (Engl Ed). 2018 Apr;109(3):278-281. doi: 10.1016/j.ad.2017.07.015. Epub 2017 Oct 23.
[Article in English, Spanish]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Administration, Oral
  • Anticoagulants / administration & dosage
  • Dermatology
  • Factor Xa Inhibitors / administration & dosage*
  • Female
  • Humans
  • Livedo Reticularis / drug therapy*
  • Middle Aged
  • Rivaroxaban / administration & dosage*

Substances

  • Anticoagulants
  • Factor Xa Inhibitors
  • Rivaroxaban